TSC2 and hepatocellular carcinoma: The median age at surgery was 11 years (IQR: 1.55–15.5), and the indications for surgery included HB (n = 1), HCC (n = 1), hepatic angiomyolipoma associated with a TSC-2 mutation (n = 1), large β-catenin mutated hepatic adenoma (n = 1), and hepatic mesenchymal hamartoma (n = 1).